About
Tioga Cardiovascular is a medical device company focused on developing innovative transcatheter mitral valve replacement (TMVR) systems for treating mitral regurgitation, a common heart valve disease. As a portfolio entity of Shifamed LLC, the company aims to create valve replacement solutions that are simpler and less invasive than traditional surgical methods. The core product in development is a next-generation TMVR system designed to address both functional and degenerative mitral regurgitation. This system features a unique valve and anchor design that reduces the risk of complications and accommodates a wide range of native mitral valve sizes. Tioga Cardiovascular is committed to providing physicians and patients with a transcatheter intervention that enhances safety and efficacy in TMVR procedures. With significant funding raised in recent years, Tioga Cardiovascular is positioned to serve cardiologists and healthcare providers specializing in structural heart disease. The company focuses on improving patient outcomes and expanding treatment eligibility in the growing structural heart market.
Technologies
Keywords
Company Information
-
Employees 21
-
Founded 2019
-
Total Funding $60000000
Location
590 Division Street, Campbell, California, United States, 95008
